Home
/ Bryleos
/ Competitors

Bryleos Competitors and Similar CompaniesClear all

Bryleos's competitors and similar companies include Pfizer and Novartis.

	Bryleos Bryleos (also known as BioNADrx Holdings) is a clinical stage therapeutics company.	Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.	Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products.
Founding Date	Founding Date 2021	Founding Date 1849	Founding Date 1996
Type	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare biotech clinical research drug development oncology pharma
Locations	Locations Johnson City, US HQ	Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more	Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more
Employees	Employees 7	Employees 81,0008% decrease	Employees 75,883
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $62.6b (FY, 2025)	Revenue (est.) $56.7b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods $16.1b (FY, 2025)	Cost of goods $8.4b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit $46.5b (FY, 2025)	Gross profit $49.8b (FY, 2025)
Net income	Net income N/A	Net income $7.8b (FY, 2025)	Net income $14b (FY, 2025)
Operating ⚠
Phase III Trials Products	Phase III Trials Products N/A	Phase III Trials Products 32 (FY, 2024)	Phase III Trials Products 44 (FY, 2022)
Registration Phase Products	Registration Phase Products N/A	Registration Phase Products 5 (FY, 2024)	Registration Phase Products 8 (FY, 2022)
Funding
Total funding raised	Total funding raised $ 5m	Total funding raised N/A	Total funding raised $ 6.5m